Vancomycin-resistant enterococcus: Difference between revisions
No edit summary |
(Text replacement - " gentamicin " to " gentamicin ") |
||
| Line 5: | Line 5: | ||
==Antimicrobial Options<ref>Arias CA et al. Management of multidrug-resistant enterococcal infections. Clin Microbiol Infect. 2010 Jun; 16(6): 10.1111/j.1469-0691.</ref><ref>Rivera AM and Boucher HW. Current Concepts in Antimicrobial Therapy Against Select Gram-Positive Organisms: Methicillin-Resistant Staphylococcus aureus, Penicillin-Resistant Pneumococci, and Vancomycin-Resistant Enterococci. Mayo Clin Proc. 2011 Dec; 86(12): 1230–1243.</ref>== | ==Antimicrobial Options<ref>Arias CA et al. Management of multidrug-resistant enterococcal infections. Clin Microbiol Infect. 2010 Jun; 16(6): 10.1111/j.1469-0691.</ref><ref>Rivera AM and Boucher HW. Current Concepts in Antimicrobial Therapy Against Select Gram-Positive Organisms: Methicillin-Resistant Staphylococcus aureus, Penicillin-Resistant Pneumococci, and Vancomycin-Resistant Enterococci. Mayo Clin Proc. 2011 Dec; 86(12): 1230–1243.</ref>== | ||
*[[Gentamicin]] 1 mg/kg q8hrs IV | *[[Gentamicin]] 1 mg/kg q8hrs IV | ||
**Use [[streptomycin]] for gentamicin resistance | **Use [[streptomycin]] for [[gentamicin]] resistance | ||
**Add [[ampicillin]] 12 g q24hrs IV if treating [[endocarditis]] or [[vancomycin]] if suspicious for MRSA | **Add [[ampicillin]] 12 g q24hrs IV if treating [[endocarditis]] or [[vancomycin]] if suspicious for MRSA | ||
*[[Linezolid]] 600 mg PO/IV q12hrs, with exception of bacteremia since agent is bacteriostatic | *[[Linezolid]] 600 mg PO/IV q12hrs, with exception of bacteremia since agent is bacteriostatic | ||
Revision as of 13:45, 8 September 2016
Background
- Enterococcus is part of normal gut flora
- Must cover both Enterococcus faecium and Enterococcus faecalis
Antimicrobial Options[1][2]
- Gentamicin 1 mg/kg q8hrs IV
- Use streptomycin for gentamicin resistance
- Add ampicillin 12 g q24hrs IV if treating endocarditis or vancomycin if suspicious for MRSA
- Linezolid 600 mg PO/IV q12hrs, with exception of bacteremia since agent is bacteriostatic
- Daptomycin 6 mg/kg q24hrs
- Cannot be used for pulmonary infection
- Daptomycin is inactivated by surfactant by in vitro studies
See Also
Sources
- ↑ Arias CA et al. Management of multidrug-resistant enterococcal infections. Clin Microbiol Infect. 2010 Jun; 16(6): 10.1111/j.1469-0691.
- ↑ Rivera AM and Boucher HW. Current Concepts in Antimicrobial Therapy Against Select Gram-Positive Organisms: Methicillin-Resistant Staphylococcus aureus, Penicillin-Resistant Pneumococci, and Vancomycin-Resistant Enterococci. Mayo Clin Proc. 2011 Dec; 86(12): 1230–1243.